Загрузка видео...

Не удалось загрузить видео

Возникла проблема при загрузке этого видео. Это может быть связано с временными проблемами сети или видео может быть недоступно.

На главную

Ivermectin and Mebendazole, which are being used off-label as potential breakthroughs in cancer treatment, were not originally developed for that purpose. However, they are proving effective against tumors and providing new hope for patients. It is essential for pharmaceutical companies to endorse these medications officially for cancer therapy. #Ivermectin... show more

Joe Tippens

91,258 subscribers

266,039 просмотров • 1 год назад •via X (Twitter)

Здоровье и велнес Наука и технологии Образование

Anya Rossi• Live Now

Private livecam show

Комментарии: 4

Фото профиля Linda Traitz

Linda Traitz1 год назад

Thank you for sharing this important information My husband and I take ivermectin paste and fenbendazole every day just for preventative purposes. I'm happy you found this cure for cancer

Фото профиля The Storm Is Queue'd 🫡🙏🇺🇲

The Storm Is Queue'd 🫡🙏🇺🇲1 год назад

You Sir, are a walking miracle!! 🙏 There are literally tons of PATENTS for #CancerCures AND #CANCER itself!!! dating back DECADES 🤬 Search 'US and International Patents Online' INFURIATING 2c every fkn "disease" & "virus" & cure in there, including (for) aids, coronavirus, Sars, mers, you name it it's fkn there! 🤬 AND THEY GET PAID (millions/billions) in ROYALTIES 4 effing us up....

Фото профиля Lu

Lu1 год назад

So not fenben?

Фото профиля Mesothelioma Claims Center

Mesothelioma Claims Center1 год назад

An estimated $30 Billion has been set aside in asbestos trust funds for victims of mesothelioma and other asbestos-related cancers. Submit the simple form below or call 866-269-3435 to file a claim now.

Похожие видео

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Dr. Zakaria MD

46,602 просмотров • 25 дней назад

Mebendazole and Off Label Use in Cancer Research Repurposed medications are drawing renewed attention as researchers explore cost-effective cancer approaches. Mebendazole, long used as an antiparasitic, is now being examined for its anti-cancer properties, with growing interest in oversight, data collection, and responsible off-label use. Support Independent Research: Credit: Faith & Freedom — Shemane Nugent | Real America's Voice (RAV) #MedicalFreedom

Mebendazole and Off Label Use in Cancer Research Repurposed medications are drawing renewed attention as researchers explore cost-effective cancer approaches. Mebendazole, long used as an antiparasitic, is now being examined for its anti-cancer properties, with growing interest in oversight, data collection, and responsible off-label use. Support Independent Research: Credit: Faith & Freedom — Shemane Nugent | Real America's Voice (RAV) #MedicalFreedom

McCullough Foundation

43,568 просмотров • 5 месяцев назад

World Ivermectin Day 2024: "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". There is no money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, Mebendazole For example, Fenbendazole and Mebendazole upregulate p53 tumor suppressor levels, that are low in people who took COVID-19 Vaccines and developed Turbo Cancer

World Ivermectin Day 2024: "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". There is no money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, Mebendazole For example, Fenbendazole and Mebendazole upregulate p53 tumor suppressor levels, that are low in people who took COVID-19 Vaccines and developed Turbo Cancer

IvermectinKart | Ivermectin & Cancer cure store

1,876,317 просмотров • 9 месяцев назад

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 просмотров • 1 месяц назад

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,701 просмотров • 1 год назад

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."

Sense Receptor

227,993 просмотров • 8 месяцев назад

Combination of Ivermectin-Mebendazole Considered for Off-Label Anti-neoplastic Effects Dr. McCullough told Grant Stinchfield that when patients have exhausted all conventional cancer treatment, patients and doctors are considering this combination. Large prospective, randomized, double blind clinical trials are warranted in common cancers. The Wellness Company Grant Stinchfield National Cancer Institute MD Anderson News McCullough Foundation

Combination of Ivermectin-Mebendazole Considered for Off-Label Anti-neoplastic Effects Dr. McCullough told Grant Stinchfield that when patients have exhausted all conventional cancer treatment, patients and doctors are considering this combination. Large prospective, randomized, double blind clinical trials are warranted in common cancers. The Wellness Company Grant Stinchfield National Cancer Institute MD Anderson News McCullough Foundation

Peter A. McCullough, MD, MPH®

297,056 просмотров • 1 год назад

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

skymeds store | Online Ivermectin Pharmacy

5,142,525 просмотров • 1 год назад

An infuriated Dr John Campbell says the latest cancer study is remarkable and shows we could be curing the world of cancer with ivermectin/ mebendazole. He breaks it down: • 197 patients took 25mg ivermectin and 250 mg mebendazole daily for 90 days: • 84% had a positive response • only 15.6% had cancer progression • the combination appears to be effective against a very wide range of cancers. ‘It just drives you mad really these studies are crying out to be done’

An infuriated Dr John Campbell says the latest cancer study is remarkable and shows we could be curing the world of cancer with ivermectin/ mebendazole. He breaks it down: • 197 patients took 25mg ivermectin and 250 mg mebendazole daily for 90 days: • 84% had a positive response • only 15.6% had cancer progression • the combination appears to be effective against a very wide range of cancers. ‘It just drives you mad really these studies are crying out to be done’

Kat A 🌸

194,551 просмотров • 3 месяцев назад

At The Wellness Company we are not making drug advertising claims; we are simply telling you what patients reported to us when they used our combination ivermectin-mebendazole, off-label, as an adjunct to the traditional cancer treatment regimen. Our report is a strong impetus for the National Cancer Institute to do a large, prospective, double-bind, randomized, placebo-controlled, parallel group trial in a broad array of cancer patients. The Wellness Company Dr. Gina

At The Wellness Company we are not making drug advertising claims; we are simply telling you what patients reported to us when they used our combination ivermectin-mebendazole, off-label, as an adjunct to the traditional cancer treatment regimen. Our report is a strong impetus for the National Cancer Institute to do a large, prospective, double-bind, randomized, placebo-controlled, parallel group trial in a broad array of cancer patients. The Wellness Company Dr. Gina

Peter A. McCullough, MD, MPH®

18,209 просмотров • 2 месяцев назад

Oncologist Dr. William Makis on the use of ivermectin, mebendazole and fenbendazole in the treatment of cancer. "What I have found working with these antiparasitics is that there is a benefit to patients in at least 75% of the cases."

Oncologist Dr. William Makis on the use of ivermectin, mebendazole and fenbendazole in the treatment of cancer. "What I have found working with these antiparasitics is that there is a benefit to patients in at least 75% of the cases."

Dr. David

39,731 просмотров • 6 дней назад

BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published! (4 min 52 seconds) InfoWars did a media piece on this breakthrough in Cancer Treatment. These are Critical medicines to have on hand. They ship from outside the USSA by our Freedom Crew. They cannot be stopped by lunatic big pharma control freaks. FREEDOM MEDICINE for the WIN "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". Big Pharma stands to make No Big Money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, and Turmeric (curcumin). For example, Fenbendazole upregulates p53 tumor suppressor levels, that are low in people who took COVID-19 injections and developed Turbo Cancer. Please Share! #Fenbendazole #ivermectin #Menbendazole #Cancercure

BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published! (4 min 52 seconds) InfoWars did a media piece on this breakthrough in Cancer Treatment. These are Critical medicines to have on hand. They ship from outside the USSA by our Freedom Crew. They cannot be stopped by lunatic big pharma control freaks. FREEDOM MEDICINE for the WIN "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". Big Pharma stands to make No Big Money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, and Turmeric (curcumin). For example, Fenbendazole upregulates p53 tumor suppressor levels, that are low in people who took COVID-19 injections and developed Turbo Cancer. Please Share! #Fenbendazole #ivermectin #Menbendazole #Cancercure

Joe Tippens

100,666 просмотров • 8 месяцев назад

1. "Ivermectin: A Supercharged Cancer Fighter" Ivermectin is proving to be up to 7 times more effective than conventional treatments in disrupting cancer’s survival mechanisms. With just a single dose, it strikes cancer cells through multiple pathways and helps block the formation of new tumors, both at the original site and in areas where cancer might spread. #Fenbendazole #Ivermectin #Cancercure

1. "Ivermectin: A Supercharged Cancer Fighter" Ivermectin is proving to be up to 7 times more effective than conventional treatments in disrupting cancer’s survival mechanisms. With just a single dose, it strikes cancer cells through multiple pathways and helps block the formation of new tumors, both at the original site and in areas where cancer might spread. #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

78,082 просмотров • 8 месяцев назад

MERRY CHRISTMAS!! 😃☦️ I hope you all had an amazing Christmas! We are now helping 7800+ Cancer patients with repurposed drugs (Ivermectin, Mebendazole, Fenbendazole) including 100 children. 👏 God bless you all for your incredible support!!

MERRY CHRISTMAS!! 😃☦️ I hope you all had an amazing Christmas! We are now helping 7800+ Cancer patients with repurposed drugs (Ivermectin, Mebendazole, Fenbendazole) including 100 children. 👏 God bless you all for your incredible support!!

Dr. William Makis MD

178,350 просмотров • 7 месяцев назад

Mel Gibson wasn't lying to Joe Rogan.... and our study just confirmed it. 84.4% of cancer patients taking ivermectin & mebendazole for 6 months declared their cancer: DISAPPEARED (32.8%) SHRUNK (15.6%) STOPPED SPREADING (36.1%)

Mel Gibson wasn't lying to Joe Rogan.... and our study just confirmed it. 84.4% of cancer patients taking ivermectin & mebendazole for 6 months declared their cancer: DISAPPEARED (32.8%) SHRUNK (15.6%) STOPPED SPREADING (36.1%)

Nicolas Hulscher, MPH

854,288 просмотров • 3 месяцев назад

🚨World Renowned Cancer Biologist Professor Thomas Seyfried reveals new Ivermectin studies underway for cancer He also presents a new paper on how anti parasitics like Mebendazole and Fenbendazole work Dr. Dominic D’Agostino from University of South Florida mentions he's just received a grant proposal from team DESANTIS, who is investing in Ivermectin and Metabolic Therapies for cancer. D’Agostino - "My Blood Levels of Ivermectin are off the charts" SEYFRIED - "we were planning to do ivermectin studies, but it became such a hot political topic I didn't want to get into it.. but we have a paper in Bio Archives now... it's under review for a bigger journal, on mebendazole the parasite medication" "Knowing that mebendazole targets glycolysis and glutaminolysis pathways... [and] when you put it under calorie restricted ketosis it works really really well" "We haven't tested ivermectin yet but we we have that in the plan" Stunningly, Seyfried mentions how Nutritional Ketosis is the key that unlocks the power of Anti Parasitics.

🚨World Renowned Cancer Biologist Professor Thomas Seyfried reveals new Ivermectin studies underway for cancer He also presents a new paper on how anti parasitics like Mebendazole and Fenbendazole work Dr. Dominic D’Agostino from University of South Florida mentions he's just received a grant proposal from team DESANTIS, who is investing in Ivermectin and Metabolic Therapies for cancer. D’Agostino - "My Blood Levels of Ivermectin are off the charts" SEYFRIED - "we were planning to do ivermectin studies, but it became such a hot political topic I didn't want to get into it.. but we have a paper in Bio Archives now... it's under review for a bigger journal, on mebendazole the parasite medication" "Knowing that mebendazole targets glycolysis and glutaminolysis pathways... [and] when you put it under calorie restricted ketosis it works really really well" "We haven't tested ivermectin yet but we we have that in the plan" Stunningly, Seyfried mentions how Nutritional Ketosis is the key that unlocks the power of Anti Parasitics.

Humanspective

45,190 просмотров • 5 месяцев назад

Oncologist Dr. William Makis describes getting attacked by the president of City of Hope cancer centers for publishing success stories using antiparasitics to treat turbo cancers: "These antiparasitics are being heavily attacked and are being suppressed every time I mention ivermectin, mebendazole, [and] fenbendazole. And I have hundreds of success stories...."

Oncologist Dr. William Makis describes getting attacked by the president of City of Hope cancer centers for publishing success stories using antiparasitics to treat turbo cancers: "These antiparasitics are being heavily attacked and are being suppressed every time I mention ivermectin, mebendazole, [and] fenbendazole. And I have hundreds of success stories...."

Joe Tippens

66,174 просмотров • 6 месяцев назад

Dr. William Makis exposes a monumental hypocrisy in the cancer world. Fenbendazole is dismissed as a "dog dewormer," while its near-identical human counterpart, Mebendazole, is a recognized human antiparasitic. But there's a catch. Johns Hopkins, an institution central to the COVID-19 narrative, holds a patent on Mebendazole for cancer—specifically for brain cancers. Seeing this, Dr. Makis began advising terminal patients to try repurposed antiparasitics like Ivermectin and Fenbendazole. The results were not just promising; they were miraculous. Stage four cancer patients started returning with unbelievable news: "My tumors are shrinking." "My oncologist told me I should be dead." "I'm alive because of you." Their stories are a testament to the life-saving potential of these demonized drugs. While institutions play games with patents and narratives, real people are getting their lives back.

Dr. William Makis exposes a monumental hypocrisy in the cancer world. Fenbendazole is dismissed as a "dog dewormer," while its near-identical human counterpart, Mebendazole, is a recognized human antiparasitic. But there's a catch. Johns Hopkins, an institution central to the COVID-19 narrative, holds a patent on Mebendazole for cancer—specifically for brain cancers. Seeing this, Dr. Makis began advising terminal patients to try repurposed antiparasitics like Ivermectin and Fenbendazole. The results were not just promising; they were miraculous. Stage four cancer patients started returning with unbelievable news: "My tumors are shrinking." "My oncologist told me I should be dead." "I'm alive because of you." Their stories are a testament to the life-saving potential of these demonized drugs. While institutions play games with patents and narratives, real people are getting their lives back.

Camus

238,737 просмотров • 9 месяцев назад

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 просмотров • 1 год назад

🚨🇺🇸 “They overcame Stage 4 Cancer” “Generic Drug Repurposing, which includes drugs like Ivermectin” Whoe Florida are going to invest to see if Drugs like Ivermectin can be used to treat Cancer, even though there is no money for Pharmaceutical Companies to make from it. Many people believe Cancer is caused by Parasites in the body & guess what - Ivermectin kills Parasites. Florida already know the answer.

🚨🇺🇸 “They overcame Stage 4 Cancer” “Generic Drug Repurposing, which includes drugs like Ivermectin” Whoe Florida are going to invest to see if Drugs like Ivermectin can be used to treat Cancer, even though there is no money for Pharmaceutical Companies to make from it. Many people believe Cancer is caused by Parasites in the body & guess what - Ivermectin kills Parasites. Florida already know the answer.

Concerned Citizen

119,761 просмотров • 10 месяцев назад